「pr」の検索結果
238件：161～165件目を表示
-
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
http://www.senju.co.jp/english/about/ -
产品开发方针 | 研究与开发 | 千寿制药株式会社
。 #1: 井上 佐智子, 川岛 素子, 坪田 一男：什么是干眼症？从原因到最新的治疗，Farumashia，2014 50(3): 201-6 #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-66. #3: Uni...
http://www.senju.co.jp/chinese/rd/policy/ -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye...
http://www.senju.co.jp/english/rd/pipeline.html -
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann...
http://www.senju.co.jp/english/news/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Lake City, Utah, United States of America Effects of a novel TRPV1 antagonist, SJP-0132, on CCL5 expression in corneal epithelial cells Yuya Atsumi, Toshizo Sato, Atsuhiro Kanda ARVO 2025 開催日：2025年5月...
http://www.senju.co.jp/english/rd/society/